awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52362144-3E0AB21F-F824-4D22-9ADE-37803A94C9C7
Q52362144-3E0AB21F-F824-4D22-9ADE-37803A94C9C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52362144-3E0AB21F-F824-4D22-9ADE-37803A94C9C7
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Q52362144-3E0AB21F-F824-4D22-9ADE-37803A94C9C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52362144-3E0AB21F-F824-4D22-9ADE-37803A94C9C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e7de9b4facb7a4e7af40b307ccccb54a3052789
P2860
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.